Zolmitriptan

DRUG7 trials

Sponsors

Impax Laboratories, LLC, AstraZeneca, Acorda Therapeutics, Pamukkale University, William Stoops

Conditions

Acute Migraine HeadacheCocaine Use DisorderMigraineMigraine Headache

Early Phase 1

Cocaine and Zolmitriptan

CompletedNCT05019430

William StoopsCocaine Use Disorder

Start: 2021-10-15End: 2025-01-09Updated: 2025-08-05

Phase 1

Safety and Pharmacokinetics (PK) Study of Single Ascending Doses of CVT-427 (Zolmitriptan Inhalation Powder) In Healthy Adults

CompletedNCT02609945

Acorda TherapeuticsMigraine

Start: 2015-11-30End: 2016-04-30Updated: 2016-06-06

Phase 3

Efficacy of Zolmitriptan (Zomig) in the Treatment of Migraines in Adolescents

CompletedNCT00617695

Impax Laboratories, LLCMigraine

Start: 2003-09-30End: 2004-10-31Updated: 2024-10-02

Efficacy and Tolerability of Zolmitriptan Nasal Spray

CompletedNCT00617747

AstraZenecaMigraine

Start: 2002-09-30End: 2003-06-30Updated: 2009-04-06

Phase 4

ZAP, US. Zomig for Appropriate for Primary Care

CompletedNCT00637286

AstraZenecaMigraine

Start: 2004-07-31End: 2005-05-31Updated: 2009-04-06

Zomig - Treatment of Acute Migraine Headache in Adolescents

CompletedNCT01211145

AstraZenecaMigraine Headache

Start: 2010-09-30End: 2013-10-31Updated: 2016-05-18

Comparison of Oral Paracetamol and Zolmitriptan Efficacy in the Treatment of Acute Migraine in Emergency Department

CompletedNCT03145467

Pamukkale UniversityAcute Migraine Headache

Start: 2016-01-31End: 2017-03-31Updated: 2017-05-09

Related Papers

Efficacy and tolerability of zolmitriptan nasal spray for the treatment of acute migraine in adolescents: Results of a randomized, double-blind, multi-center, parallel-group study (TEENZ).

2016-06-2216 citations